title: Are recombinant products really infection risk free?
abstract: Biological medicinal products can be manufactured from a variety of sources. Recombinant products are currently produced from extremely well characterised cells grown in vitro and priori pose the lowest risk of transmitting infection. Validated production processes make a major contribution to product safety however.
authors.affiliation: National Institute for Biological Standards and Control, Potters Bar Hertfordshire, UK. pminor@nibsc.ac.uk
authors.forename: P D
authors.initials: PD
authors.lastname: Minor
mesh_terms: D001779:Blood Coagulation Factors / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D012306:Risk; D014777:Virus Diseases / Q000635:transmission*
chemical_list: D001779:Blood Coagulation Factors; D011994:Recombinant Proteins